Nishihara Ryo, Dokainish Hisham M, Kihara Yoshiki, Ashiba Hiroki, Sugita Yuji, Kurita Ryoji
National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan.
Japan Science and Technology Agency (JST), PREST, 4-1-8, Honcho, Kawaguchi, Saitama 332-0012, Japan.
ACS Cent Sci. 2024 Jan 17;10(2):283-290. doi: 10.1021/acscentsci.3c00887. eCollection 2024 Feb 28.
Enzymatic reactions that involve a luminescent substrate (luciferin) and enzyme (luciferase) from luminous organisms enable a luminescence detection of target proteins and cells with high specificity, albeit that conventional assay design requires a prelabeling of target molecules with luciferase. Here, we report a luciferase-independent luminescence assay in which the target protein directly catalyzes the oxidative luminescence reaction of luciferin. The SARS-CoV-2 antigen (spike) protein catalyzes the light emission of luciferin, whereas no such catalytic function was observed for salivary proteins. This selective luminescence reaction is due to the enzymatic recognition of the 3-(1-guanidino)propyl group in luciferin at the interfaces between the units of the spike protein, allowing a specific detection of the spike protein in human saliva without sample pretreatment. This method offers a novel platform to detect virus antigens simply and rapidly without genetic manipulation or antibodies.
涉及来自发光生物的发光底物(荧光素)和酶(荧光素酶)的酶促反应能够以高特异性对靶蛋白和细胞进行发光检测,尽管传统的检测设计需要用荧光素酶对靶分子进行预标记。在此,我们报告了一种无需荧光素酶的发光检测方法,其中靶蛋白直接催化荧光素的氧化发光反应。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗原(刺突)蛋白催化荧光素发光,而唾液蛋白则未观察到这种催化功能。这种选择性发光反应是由于在刺突蛋白各单元之间的界面处对荧光素中3-(1-胍基)丙基的酶促识别,从而无需样品预处理即可在人唾液中特异性检测刺突蛋白。该方法提供了一个无需基因操作或抗体即可简单快速检测病毒抗原的新平台。